Evidence map›Paper›PMID 36580718›Full record

ArticleBiomaterials2023

Regional and disease specific human lung extracellular matrix composition.

Evan T Hoffman, Franziska E Uhl, Loredana Asarian, Bin Deng, Chloe Becker, Juan J Uriarte, Isaac Downs, Brad Young, Daniel J Weiss

Open access · greenAbstract read
In one paragraph

Article in Biomaterials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
9.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Hallmarks of the ageing lung: 10 years later.The European respiratory journal · 2026
    Review
  6. Article
  7. Mechanobiology and Resolution of Lung Fibrosis.Annual review of physiology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary.American journal of respiratory cell and molecular biology · 2025
    Article
  15. Review
  16. Basement membranes in lung development, disease, and repair.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  17. Article
  18. Review
  19. Study on the changes of extracellular matrix morphology and components in COPD animal model by using lung decellularized scaffold.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Evan T HoffmanDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA. Electronic address: Daniel.weiss@med.uvm.edu.
Franziska E UhlDepartment of Experimental Medical Science, Lund University, Lund, Sweden; Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.
Loredana AsarianDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
Bin DengDepartment of Biology, University of Vermont, Burlington, VT, 05405, USA.
Chloe BeckerDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
Juan J UriarteDepartment of Physiology, College of Medicine, University of Kentucky, Lexington, KY, 40506, USA.
Isaac DownsDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
Brad YoungDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
Daniel J WeissDepartment of Medicine, Larner College of Medicine, University of Vermont, Burlington, VT, 05405, USA.
University of Vermont · USLund University · SEUniversity of Kentucky · US

Funding

Vermont INBRE Administrative Supplement 2024 AWD 118P20GM103449 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI Julie Dragon · 2012 to 2026
$58.4M
Optimizing Functional Recellularization of Acellular Human Lung ScaffoldsR01HL127144 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI WEISS, DANIEL J · 2015 to 2018
$1.5M
NHLBI NIH HHS R01 HL127144NIGMS NIH HHS P20 GM103449
6 · The paper itself

Abstract

Chronic lung diseases, such as chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF), are characterized by regional extracellular matrix (ECM) remodeling which contributes to disease progression. Previous proteomic studies on whole decellularized lungs have provided detailed characterization on the impact of COPD and IPF on total lung ECM composition. However, such studies are unable to determine the differences in ECM composition between individual anatomical regions of the lung. Here, we employ a post-decellularization dissection method to compare the ECM composition of whole decellularized lungs (wECM) and specific anatomical lung regions, including alveolar-enriched ECM (aECM), airway ECM (airECM), and vasculature ECM (vECM), between non-diseased (ND), COPD, and IPF human lungs. We demonstrate, using mass spectrometry, that individual regions possess a unique ECM signature characterized primarily by differences in collagen composition and basement-membrane associated proteins, including ECM glycoproteins. We further demonstrate that both COPD and IPF lead to alterations in lung ECM composition in a region-specific manner, including enrichment of type-III collagen and fibulin in IPF aECM. Taken together, this study provides methodology for future studies, including isolation of region-specific lung biomaterials, as well as a dataset that may be applied for the identification of novel ECM targets for therapeutics.

Indexed as

Extracellular MatrixExtracellular Matrix ProteinsIdiopathic Pulmonary FibrosisLungPulmonary Disease, Chronic ObstructiveCollagenHumansProteomicsCollagenExtracellular Matrix ProteinsDecellularizationExtracellular matrixLungProteomics

Identifiers

PMID36580718
PMCPMC9868084
OpenAlexW4313313098

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.